Abstract: Provided herein are systems and methods for processing biomolecules (e.g., nucleic acid molecules, proteins) from a sample. A method for processing biomolecules may comprise hybridizing a probe molecule to a target region of a nucleic acid molecule (e.g., a ribonucleic acid (RNA) molecule) and barcoding the probe-nucleic acid molecule complex or derivatives thereof. Such a method can comprise performing a nucleic acid reaction, e.g., extension, denaturation, and amplification. A method for processing a sample may comprise hybridizing probes to (i) target regions of a nucleic acid molecule (e.g., RNA molecule) and (ii) a reporter oligonucleotide of a feature binding group, and barcoding the probe-associated molecules. One or more processes of the methods described herein may be performed within a partition, such as a droplet or well.

Abstract: The present invention relates to the use of a combination of two different cannabinoids in the treatment of leukaemia. The combination of CBD with THC appears to be particularly effective in reducing cell number in this disease. Preferably the cannabinoids are used in the form of an extract of cannabis such that many of the naturally occurring compounds are co-extracted with the THC or CBD. Alternatively, the cannabinoids are present in the form of a highly purified extract of cannabis, wherein the CBD or THC are present at greater than 98% of the total extract (w/w) and the other components of the extract are characterized. Alternatively, the CBD and THC may be synthetically produced. A specific ratio of CBD and THC such as 10:1 to 1:10 (CBD:THC) or more preferably between 2:1 to 1:2 (CBD:THC) may be used.

Abstract: The present invention relates to the use of a combination of two different cannabinoids in the treatment of leukaemia. The combination of CBD with THC appears to be particularly effective in reducing cell number in this disease. Preferably the cannabinoids are used in the form of an extract of Cannabis such that many of the naturally occurring compounds are co-extracted with the THC or CBD. Alternatively, the cannabinoids are present in the form of a highly purified extract of Cannabis, wherein the CBD or THC are present at greater than 98% of the total extract (w/w) and the other components of the extract are characterised. Alternatively, the CBD and THC may be synthetically produced. A specific ratio of CBD and THC such as 10:1 to 1:10 (CBD:THC) or more preferably between 2:1 to 1:2 (CBD:THC) may be used.

Abstract: The present invention relates to the use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer. Preferably the phytocannabinoids used are either tetrahydrocannabinol (THC) and/or cannabidiol (CBD). Preferably the type of cancer to be treated is glioma.

Abstract: The present invention relates to the use of a combination of two different cannabinoids in the treatment of leukaemia. The combination of CBD with THC appears to be particularly effective in reducing cell number in this disease. Preferably the cannabinoids are used in the form of an extract of cannabis such that many of the naturally occurring compounds are co-extracted with the THC or CBD. Alternatively, the cannabinoids are present in the form of a highly purified extract of cannabis, wherein the CBD or THC are present at greater than 98% of the total extract (w/w) and the other components of the extract are characterised. Alternatively, the CBD and THC may be synthetically produced. A specific ratio of CBD and THC such as 10:1 to 1:10 (CBD:THC) or more preferably between 2:1 to 1:2 (CBD:THC) may be used.

Abstract: The present invention relates to the use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer. Preferably the phytocannabinoids used are either tetrahydrocannabinol (THC) and/or cannabidiol (CBD). Preferably the type of cancer to be treated is glioma.

Abstract: The present invention relates to the use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer. Preferably the phytocannabinoids used are either tetrahydrocannabinol (THC) and/or cannabidiol (CBD). Preferably the type of cancer to be treated is glioma.

Abstract: Systems and methods expedite and improve the process of configuring an augmented reality environment. A method of pose determination according to the invention includes the step of placing at least one synthetic fiducial in a real environment to be augmented. A camera, which may include apparatus for obtaining directly measured camera location and orientation (DLMO) information, is used to acquire an image of the environment. The natural and synthetic fiducials are detected, and the pose of the camera is determined using a combination of the natural fiducials, the synthetic fiducial if visible in the image, and the DLMO information if determined to be reliable or necessary. The invention is not limited to architectural environments, and may be used with instrumented persons, animals, vehicles, and any other augmented or mixed reality applications.

Abstract: An improved augmented reality (AR) system integrates a human interface and computing system into a single, hand-held device. A touch-screen display and a rear-mounted camera allows a user interact the AR content in a more intuitive way. A database storing graphical images or textual information about objects to be augmented. A processor is operative to analyze the imagery from the camera to locate one or more fiducials associated with a real object, determine the pose of the camera based upon the position or orientation of the fiducials, search the database to find Graphical images or textual information associated with the real object, and display graphical images or textual information in overlying registration with the imagery from the camera.

Abstract: A method for controlling a graphical user interface (GUI) for a touchscreen-enabled computer systems provides a variety of software methods (tools) provide for high-fidelity control of the user interface. The TrackScreen tool provides finger-friendly mouse functions such as scrolling, dragging and clicking. The Magnifier application continuously captures the current screen image, and displays a magnified subset of it. Selecting within this magnified area with a pointing device (mouse, touchscreen, digitizer, etc) causes the application to simulate the action on the portion of the screen corresponding to the point in the magnified image that was selected. A KeyBoard application, a keyboard is rendered on screen, with sufficient size that the individual keys are easily selectable with an unaided finger. The Common Tasks Tool or CTT) allows common keyboard shortcuts, mouse events, and other user interface events to be specified in a configuration file and represented on screen as a large, easy-to-click button.

Abstract: This invention relates to a cookbook which can be positioned on a support surface. The cookbook is made of three sidewalls which form a generally triangular formation which can stand on the support surface. A plurality of sheets containing food recipe data are positioned to overlie one of the sidewalls.